(R)-PROTAC CDK9 ligand-1

• UNSPSC Description:

  (R)-PROTAC CDK9 ligand-1 (Compound 19.4) is a CDK9-targeting degrader that can be used to synthesize PROTAC with antitumor activity[1].

• Target Antigen:

  CDK; Ligands for Target Protein for PROTAC

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;PROTAC

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/r-protac-cdk9-ligand-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C1=C2N=C(N[C@@H](CO)CC)C=C(NCC3=CC=C(N)C=C3)N2N=C1)C

• Molecular Weight:

  368.48

• References & Citations:

  [1]Xiaohua Chen, et al. Preparation of degradation agents for cyclin dependent kinase useful for the treatment of cancer. Patent CN110835345A.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2411021-95-7